Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cvrx, Inc. (CVRX)
:CVRX
CVRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.40 - $22.86
Previous CloseN/A
Volume20.10K
Average Volume (3M)259.19K
Market Cap
$364.76M
Enterprise Value$257.65M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.25
Next Earnings
Apr 23, 2025EPS Estimate
-0.54Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.70
Shares Outstanding26,036,032
10 Day Avg. Volume192,530
30 Day Avg. Volume259,188
Standard Deviation0.28
R-Squared0.05
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.45
Price to Cash Flow (P/CF)-8.50
P/FCF Ratio0.00
Enterprise Value/Market Cap0.71
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.80
Enterprise Value/Ebitda-4.75
Forecast
1Y Price Target
$19.40Price Target Upside38.47% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
---
Bulls Say, Bears Say
Bulls Say
Clinical EvidenceReal-world evidence shows significant reduction in hospitalization - strengthens use case beyond QoL.
Financial PerformanceCVRx announced final Q4 revenue of $15.3M which shows a year-over-year increase of 36% and a quarter-over-quarter increase of 15%.
Market PotentialCVRx is considered to have a 'scarcity' value as a high-growth cardiovascular MedTech company with solid gross margins in a multibillion-dollar total addressable market.
Bears Say
Data LimitationsLimitations to this data included that the study was run by CVRX and used a claims database with a lack of control group.
Operational ExpensesManagement expects OpEx of $100M-$104M, above our $92.8M FY25 estimate.
Outpatient ReimbursementThere is continued uncertainty around outpatient reimbursement for 2026, but it is not viewed as a significant risk to the stock price.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CVRX FAQ
What was Cvrx, Inc.’s price range in the past 12 months?
Cvrx, Inc. lowest stock price was $6.40 and its highest was $22.86 in the past 12 months.
What is Cvrx, Inc.’s market cap?
Cvrx, Inc.’s market cap is $364.76M.
When is Cvrx, Inc.’s upcoming earnings report date?
Cvrx, Inc.’s upcoming earnings report date is Apr 23, 2025 which is in 60 days.
How were Cvrx, Inc.’s earnings last quarter?
Cvrx, Inc. released its earnings results on Feb 04, 2025. The company reported -$0.43 earnings per share for the quarter, missing the consensus estimate of -$0.375 by -$0.055.
Is Cvrx, Inc. overvalued?
According to Wall Street analysts Cvrx, Inc.’s price is currently Undervalued.
Does Cvrx, Inc. pay dividends?
Cvrx, Inc. does not currently pay dividends.
What is Cvrx, Inc.’s EPS estimate?
Cvrx, Inc.’s EPS estimate is -0.54.
How many shares outstanding does Cvrx, Inc. have?
Cvrx, Inc. has 26,036,032 shares outstanding.
What happened to Cvrx, Inc.’s price movement after its last earnings report?
Cvrx, Inc. reported an EPS of -$0.43 in its last earnings report, missing expectations of -$0.375. Following the earnings report the stock price went down -7.2%.
Which hedge fund is a major shareholder of Cvrx, Inc.?
Currently, no hedge funds are holding shares in CVRX
---
CVRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.40 (38.47% Upside)
$19.40 (38.47% Upside)
Blogger Sentiment
Neutral
CVRX Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 159.0 Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $19.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 5.6%
Last 30 Days ▲ 18.1%
Last 30 Days ▲ 18.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-37.00%
12-Months-Change
Fundamentals
Return on Equity
-81.58%
Trailing 12-Months
Asset Growth
15.78%
Trailing 12-Months
Company Description
Cvrx, Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases.
---
CVRX Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and successful expansion in the U.S. market, alongside key reimbursement milestones and educational initiatives. However, challenges were noted in the European market, and there were increased operating expenses and interest expenses leading to a higher net loss.Read More>---
CVRX Stock 12 Month Forecast
Average Price Target
$19.40
▲(38.47% Upside)
Technical Analysis
Best Analysts Covering CVRX
1 Year
1 Year Success Rate
11/18 ratings generated profit
1 Year Average Return
+26.73%
reiterated a buy rating 18 days ago
Copying Matthew O'Brien's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +26.73% per trade.
---